Kavita V. Nair, PhD
CU Skaggs School of Pharmacy & Pharmaceutical Sciences, Anschutz Medical Campus
Titles and Affiliations:
- Professor of Neurology and Pharmacy, CU Skaggs School of Pharmacy & Pharmaceutical Sciences, Anschutz Medical Campus
Dr. Kavita V. Nair is Professor in Department of Neurology and the Center of Pharmaceutical Outcomes Research with 25 years of experience including 15 years in current position at one of the nation’s leading academic medical centers. Her focus is on real-world outcomes research in adult neurology, particularly pioneering work in comparing drug treatments for multiple sclerosis (MS) and applying findings to rare neurological diseases with emphasis on three broad areas:
- Examining the comparative effectiveness of disease-modifying treatments in the management of neurological disease, specifically MS and contributing to a better understanding of how new drug therapies in multiple sclerosis compare on real-world effectiveness, safety, tolerability, and cost. This research includes pioneering triangulated comparison measures from multiple data sources: (a) radiographic magnetic imaging resonance measures; (b) clinically administered assessments of mobility and cognition; (c) blood-based biomarkers of neuronal and axonal damage; (d) validated patient-reported outcomes; (e) disease clinical history from electronic medical records; (f) resource use and cost of care across sites from claims (billing) data and death records in conducting comparative effectiveness-based outcomes research.
- Translating this work in rare neurological diseases that include NMOSD and Myasthenia Gravis across a spectrum of diverse populations.
- Advocating for prescription drug policy reform at the state level on drug pricing and education of cost-effectiveness for neurologists at the national level.
She has published over 130 papers and is responsible for $20M in extra-mural funding as a Principal and Co-Principal investigator achieving equitable access to disease-modifying treatments in managing neurological diseases.